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The present study evaluated the anti-Helicobacter pylori activity of Alchemilla glabra Neygenf. (A. sect. Alchemilla), A. monticola Opiz (A. sect. Plicatae S.E. 
Fröhner), A. fissa Günther & Schummel (A. sect. Calycinae (Buser) Buser) and A. viridiflora Rothm. (A. sect. Calycinae), and identified ellagic acid and 
quercetin-3-O-β-D-glucoside. Anti-H. pylori activity was tested against ten clinical isolates and one reference strain (ATCC 43504). The methanol extracts 
were more active than the dichloromethane and cyclohexane extracts. The ranges of concentrations were between 4 μg/mL for methanol extracts of                 
A. viridiflora, A. glabra and A. monticola, and 256 μg/mL for cyclohexane extracts of A. viridiflora, A. glabra and A. fissa. The best overall activity was 
obtained with A. monticola extracts. No significant difference was found in the ellagic acid contents of the methanol extracts of the tested Alchemilla species 
(0.2-0.3 mg/mL), and anti-H. pylori activity was similar (4 μg/mL-32 μg/mL). Ellagic acid exhibited strong activity at very low concentrations (0.125-0.5 
μg/mL), while the second identified compound, quercetin-3-O-β-D-glucoside, was also very active in concentration of 2-16 μg/mL. 
 
Keywords: Alchemilla sp., Ellagic acid, Helicobacter pylori, Quercetin-3-O-β-D-glucoside. 
 
 
Helicobacter pylori (H. pylori), a ubiquitous human pathogen, is 
a Gram-negative bacterium associated with the development of 
chronic gastritis, peptic ulcer disease, and gastric cancer [1,2]. 
Standard antibiotic therapy is often not effective due to the high 
resistance of H. pylori [3]. Plants are important sources of 
biologically active compounds with significant antimicrobial 
properties. In particular, tannin containing plants have been used 
in the treatment of gastric diseases not only because of their 
astringent effect on gastric mucosa, but also because of           
anti-H. pylori activity. Water soluble tannins, catechins and 
proanthocyanidins, as well as ellagitannins, have been shown 
previously to have anti-H. pylori activity at low concentration   
[4-7]. Ellagic acid is a potent competitive inhibitor of gastric H+, 
K+-ATPase, and thus markedly inhibits acid secretion, and stress-
induced gastric lesions. Enzyme inhibition was also evident for 
tannic acid [8,9].  
 
Various species of Alchemilla L. (Rosaceae) are used in 
traditional medicine to treat the symptoms of sore throat, for 
wound healing, against bleeding, nausea and vomiting [10]. 
Alchemilla species have potent free radical scavenging activity, 
attributed to the phenolic compounds, tannins, and flavonoid 
glycosides [11-13]. A. vulgaris s.l. has been reported to possess 
ellagitannins (agrimoniin, laevigatin F, pedunculagin), 
flavonoids, essential oil, phytosterols and aliphatic hydrocarbons 
[13-15].  
 
While the antioxidant, antimicrobial and neutrophil-modulating 
activities of A. glabra have been studied, anti-Helicobacter and 
other biological activities have not been described previously 
[16]. The present study was carried out to evaluate the anti-H. 
pylori action of A. glabra Neygenf. (A. sect. Alchemilla), A. 
monticola Opiz (A. sect. Plicatae S.E. Fröhner), A. fissa Günther 
& Schummel (A. sect. Calycinae (Buser) Buser) and A. 
viridiflora Rothm. (A. sect. Calycinae), and identified 
compounds. 
 
The total tannin content in the methanol extracts of the tested 
Alchemilla species was 4.8-12.3%, calculated as pyrogallol, while 
the quantity of ellagic acid was between 0.2-0.3 mg/mL, which 
was lower than the results of other authors for A. vulgaris s.l. 
extract (Table 1) [17,18]. Besides ellagic acid, quercetin-3-O-β-
D-glucoside was identified in the methanol extracts of A. 
monticola and A. viridiflora. 
 
 
Table 1: The content of tannins (%) and ellagic acid (mg/mL) in methanol extracts.  
 
Plant species Tannins* (%) Ellagic acid (mg/mL) 
A. glabra 8.2 0.3 
A. fissa 12.3 0.2 
A. viridiflora 4.8 0.2 
A. monticola 8.5 0.2 
                  * The results were expressed as the percentage of pyrogallol. 
 
Anti-H. pylori activity was tested against ten clinical isolates and 
one reference strain (ATCC 43504). The activity of the extracts is 
presented in Table 2. The methanol extracts were more active 
than the dichloromethane and cyclohexane extracts. The range   
of concentrations was from 4 μg/mL for methanolic extracts       
of A. viridiflora, A. glabra and A. monticola to 256 μg/mL for 
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Table 2: Anti-Helicobacter pylori activity of methanol, dichlormethane and cyclohexane extract of selected Alchemilla species (MIC, μg/mL). 
 
Strains A. viridiflora A. fissa A. glabra A. monticola M* C** 
MeOH CH2Cl2 C6H6 MeOH CH2Cl2 C6H6 MeOH CH2Cl2 C6H6 MeOH CH2Cl2 C6H6 
1. 4 128 128 8 64 128 4 64 64 4 16 8 S R 
ATCC 43504 16 64 128 16 128 128 16 128 128 8 64 64 R S 
2. 8 64 128 32 128 256 32 128 128 4 64 32 S S 
3. 4 64 64 4 64 64 4 64 64 4 32 32 S S 
4. 4 64 128 4 64 128 4 64 256 4 32 64 S R 
5. 4 128 128 8 128 256 4 128 256 8 64 64 R S 
6. 4 64 128 16 128 256 16 128 128 8 64 64 S S 
7. 4 16 128 4 64 256 4 64 128 16 32 32 S R 
8. 4 64 64 4 64 64 4 64 64 8 32 32 R R 
9. 8 128 128 8 256 256 32 256 128 8 64 64 R R 
10. 8 128 256 16 256 256 8 256 256 16 64 64 S S 
*MIC-minimal inhibitory concentration, **Metronidazole, ***Claritromycin; 1-10 – clinical isolates of Helicobacter pylori; MeOH – methanol, CH2Cl2 –dichloromethane, C6H6 – 
cyclohexane. 
 
Table 3: Anti-Helicobacter pylori activity of ellagic acid and quercetin-3-O-β-D-
glucoside (MIC μg/mL). 
1-10 – clinical isolates of Helicobacter pylori; *Metronidazole, **Claritromycin. 
 
cyclohexane extracts of A. viridiflora, A. glabra and A. fissa. The 
best overall activity was obtained with A. monticola extracts. 
 
Ellagic acid exhibited strong activity in very low concentrations 
(0.125-0.5 μg/mL), while the second identified compound, 
quercetin-3-O-β-D-glucoside was also very active in concentrations 
of 2-16 μg/mL (Table 3). Previously, ellagic acid has shown activity 
against H. pylori ATCC 10231 with MIC values of 0.125 mg/mL, 
which was in accordance with our results, and MBC values against 
H. pylori G21 and 10K of 2 μg/mL and 10 μg/mL, respectively 
[5,19]. In the same experiment, quercetin-3-O-β-D-glucoside 
possessed very low activity against H. pylori G21 and 10K with 
MBC 480 μg/mL and 240 μg/mL, respectively [19]. 
 
The high activity of the methanol extracts could be explained by the 
presence of tannins, especially ellagic acid and ellagitannins. Also, 




Plant extract preparation: Aerial parts of A. fissa and A. viridiflora 
were collected in July 2013 at Mt Suva Planina (Serbia), while A. 
monticola and A. glabra were collected in August 2013 from Mt 
Stara Planina (Serbia). Voucher specimens (20130708/1-2, 
20130708/1-2) were deposited in the Natural History Museum 
(Belgrade, Serbia) and identification of plant material was made by 
Dr Marjan Niketić. The air-dried, powdered material (380 g of A. 
fissa; 320 g of A. viridiflora; 53 g of A. glabra; 8.27 g A. monticola) 
were extracted with cyclohexane, dichlormethane and methanol, 
successively. The solvents were evaporated under low pressure to 
yield extracts.  
 
Quantification of tannins: The official spectrometric method from 
Ph. Eur. 7.0 was used for quantification of tannins in the methanol 
extracts [20]. 
 
Quantification of ellagic acid: Ellagic acid content was determined 
in methanol extracts (2 mg/mL). HPLC separation was performed 
using an Agilent 1200 Series system equipped with a G1311A 
quaternary pump, a G1329A injector and G1315D DAD detector. 
The following conditions were used: column Zorbax Eclipse XDB-
C18 (4.6 x 250 mm, 5 µm); column temperature 25oC; injection 
volume 5 µL; a flow rate 0.350 mL/min; detection at 256 and 367 
nm. The mobile phase (A) water + 0.1% formic acid and (B) 
acetonitrile was used with a linear gradient: 0-2 min from 10 to 20% 
(B), 2-4.5 min from 20 to 90% (B), 4.5-4.8 min 90% (B), 4.8-4.9 
min from 90 to 10% (B), 4.9-12.0 min 10% (B). The calibration 
curve was constructed from standard solutions of ellagic acid in 
methanol in the concentration range 0.017-0.55 mg/mL. The 
relationship between the peak area and concentration of ellagic acid 
was linear with a regression equation y=73579.63x+1232.5472. The 
correlation coefficient value corresponding to the calibration curve 
was r2=0.998. Each measurement was performed in triplicate. The 
same chromatographic conditions were used for qualitative analyses 
of quercetin-3-O-β-D-glucoside.  
 
Anti-Helicobacter pylori activity: Ten clinical isolates of H. pylori, 
including one highly resistant to metronidazole (M) (MIC > 16 
ng/ml), 3 resistant to claritromycin (C) (MIC > 1 ng/ml), 2 resistant 
to both M and C, and 4 C and M susceptible, were tested. A 
reference strain of H. pylori (ATCC 43504) was used as a control. 
The strains were maintained at -80° C in Wilkins Chalgren Broth 
(Difco) with 10%, v/v, horse serum (Seromed) and 20%, v/v, 
glycerol (Merck) until required for experiments. Before being used, 
the strains were sub-cultured twice on Columbia agar base (Difco) 
supplemented with 10% horse serum and 0.25% bacto yeast extract 
(Difco). Plates were incubated for 72 h at 37°C in an atmosphere of 
10% CO2 in a gas incubator. Before inoculation, the shape and 
motility of the organisms were controlled by Gram staining and 
phase-contrast microscopy. MICs were determined by a modified 
broth dilution method, as previously described [21]. Briefly, 
twofold serial dilution of the test compounds were prepared in a 96-
well microtiter plate containing 100 µL of MegaCellTM RPMI-
1640 medium with 3% fetal calf serum (FCS). An inoculum 
equivalent to 1 McFarland standard was prepared in Wilkins 
Chalgren broth and diluted in MegaCellTM RPMI-1640 medium 
with 3% FCS. Each well was inoculated with H. pylori at a final 
concentration of approximately 5 x 105 CFU/well. The plates were 
Strains Ellagic acid Quercetin-3-O-β-D-
glucoside 
M* C** 
ATCC 43504 0.5 8 R S 
1 0.5 16 S R 
2 0.5 16 S S 
3 0.25 4 S S 
4 0.125 4 S R 
5 0.25 16 R S 
6 0.5 16 S S 
7 0.125 4 S R 
8 0.25 4 R R 
9 0.125 8 R R 
10 0.25 2 S S 
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incubated at 37°C under microaerophilic conditions (10% CO2 in a 
gas incubator) and examined after 72 h of incubation. 
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